Results 311 to 320 of about 337,050 (372)

von Hippel-Lindau–Dependent Patterns of RNA Polymerase II Hydroxylation in Human Renal Clear Cell Carcinomas

, 2010
Ying Yi, Olga Mikhaylova, Aygun Mamedova, Prabhat Bastola, Jacek Biesiada, Enas Alshaikh, Linda Levin, Rachel Sheridan, Jarek Meller, Maria Czyzyk-Krzeska   +9 more
openalex   +1 more source

Unveiling the complexity of cellular senescence in cancers: From mechanism to therapeutic opportunities

BMEMat, EarlyView.
This review highlights the complex roles of cellular senescence in cancer progression and suppression, discusses the mechanisms and regulatory pathways involved, and evaluates the efficacy of the “One‐Two punch” sequential treatment approach while addressing emerging challenges in this novel therapeutic strategy.
Qiuming Pan, Ye Zhu, Zhi Ye, Huayang Zhang, Junxi Wang, Guozhong Yi, Zhiyong Li, Rongyang Xu, Luyao Wang, Zhenzhen Wu, Songtao Qi, Guanglong Huang, Shanqiang Qu   +12 more
wiley   +1 more source

Characterization of clear cell - Renal cell carcinoma using neutrophil - Lymphocyte ratio. [PDF]

Bioinformation
S S, Chally P, Azeez A, Patel S, Bakerywala A, Shaikh H.   +5 more
europepmc   +1 more source

The accessory renal arteries: A systematic review with meta‐analysis

Clinical Anatomy, EarlyView.
Abstract The accessory renal arteries (ARAs) are a well‐described variant of the renal vasculature with clinical implications for radiologists, surgeons, and clinicians. The aim of the present systematic review with meta‐analysis was to estimate the pooled prevalence of ARAs, including their variant number, origin, and termination, and to highlight ...
George Triantafyllou, Ioannis Paschopoulos, Andrzej Węgiel, Łukasz Olewnik, George Tsakotos, Nicol Zielinska, Maria Piagkou   +6 more
wiley   +1 more source

Systemic Treatment of Locally Advanced or Metastatic Non-Clear Cell Renal Cell Carcinoma. [PDF]

Cancers (Basel)
Vento J, Zhang T, Kapur P, Hammers H, Brugarolas J, Qin Q.   +5 more
europepmc   +1 more source

PPARγ is functionally expressed in clear cell renal cell carcinoma

, 2010
Денис
openalex   +2 more sources

A phase II basket trial of dual anti‐CTLA‐4 and anti‐PD‐1 blockade in rare tumors (DART) SWOG S1609: durable responses and delayed pseudoprogression in small cell carcinoma of the ovary, hypercalcemic type cohort

Cancer Communications, EarlyView.
Abstract Background The combined use of anti‐programmed cell death protein 1 (PD‐1)/anti‐cytotoxic T‐lymphocyte associated protein 4 (CTLA‐4) checkpoint inhibitors has been effective in various cancer types. The Southwest Oncology Group (SWOG) Dual Anti‐CTLA‐4 and Anti‐PD‐1 Blockade in Rare Tumors (DART) S1609 study investigated ipilimumab and ...
Young Kwang Chae, Megan Othus, Sandip Pravin Patel, Raid Aljumaily, Khine Z. Win, Tanya Pejovic, Sajeve S. Thomas, William R. Robinson III, Hye Sung Kim, Liam Il‐Young Chung, Christine M. McLeod, Helen X. Chen, Elad Sharon, Howard Streicher, Christopher W. Ryan, Charles D. Blanke, Razelle Kurzrock   +16 more
wiley   +1 more source

Arginine methylation modulates tumor fate and prognosis in clear cell renal cell carcinoma. [PDF]

Discov Oncol
Wang J, Bao D, Chen X, Yu Z, Kong W, Xu C, Li S, Yue Y.   +7 more
europepmc   +1 more source

Metastatic renal clear-cell carcinoma to the gallbladder: A radiologist’s perspective

, 2010
Christopher Bolus, John A. Libertino, Christoph Wald   +2 more
openalex   +1 more source

Neutrophils in cancer: At the crucial crossroads of anti‐tumor and pro‐tumor

Cancer Communications, EarlyView.
Abstract Neutrophils are important components of the immune system and play a key role in defending against pathogenic infections and responding to inflammatory cues, including cancer. Their dysregulation indicates potential disease risk factors. However, their functional importance in disease progression has often been underestimated due to their ...
Wenpeng Cai, Tao Fan, Chu Xiao, Ziqin Deng, Yixiao Liu, Chunxiang Li, Jie He   +6 more
wiley   +1 more source